Detalhe da pesquisa
1.
Outcomes after placement of a SX-ELLA oesophageal stent for refractory variceal bleeding-A national multicentre study.
Liver Int
; 39(2): 290-298, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30248224
2.
High-level ERBB2 gene amplification is associated with a particularly short time-to-metastasis, but results in a high rate of complete response once trastuzumab-based therapy is offered in the metastatic setting.
Int J Cancer
; 135(1): 224-31, 2014 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-24311197
3.
Incomplete surgical resection of ductal carcinomas in situ results in activation of ERBB2 in residual breast cancer cells.
Endocr Relat Cancer
; 16(1): 73-83, 2009 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-18948375
4.
PTEN expression as a predictor for the response to trastuzumab-based therapy in Her-2 overexpressing metastatic breast cancer.
PLoS One
; 12(3): e0172911, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28253285
5.
Hepatic dysfunction contributes to coagulation disturbances in patients undergoing whole body hyperthermia by use of extracorporeal circulation.
Int J Artif Organs
; 37(9): 1-12, 2014 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-25262634
6.
Elevation in inflammatory serum biomarkers predicts response to trastuzumab-containing therapy.
PLoS One
; 7(12): e51379, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-23300545
7.
Whole body hyperthermia by extracorporeal circulation in spontaneously breathing sarcoma patients: hemodynamics and oxygen metabolism.
Int J Artif Organs
; 34(11): 1085-94, 2011 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-22183522
8.
Quantitation of p95HER2 in paraffin sections by using a p95-specific antibody and correlation with outcome in a cohort of trastuzumab-treated breast cancer patients.
Clin Cancer Res
; 16(16): 4226-35, 2010 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-20664024